AMEERA Trademark

Trademark Overview

On Wednesday, May 27, 2020, a trademark application was filed for AMEERA with the United States Patent and Trademark Office. The USPTO has given the AMEERA trademark a serial number of 88935145. The federal status of this trademark filing is REGISTERED as of Tuesday, September 28, 2021. This trademark is owned by Sanofi. The AMEERA trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Conducting clinical trials for others in the field of oncology
ameera

General Information

Serial Number88935145
Word MarkAMEERA
Filing DateWednesday, May 27, 2020
Status700 - REGISTERED
Status DateTuesday, September 28, 2021
Registration Number6496263
Registration DateTuesday, September 28, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 13, 2021

Trademark Statements

Goods and ServicesConducting clinical trials for others in the field of oncology

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, June 15, 2020
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSanofi
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressParis 75017
FR
Party NameSanofi
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressParis 75008
FR
Party NameSanofi
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressParis 75008
FR

Trademark Events

Event DateEvent Description
Friday, March 3, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, March 3, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, March 3, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, March 3, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, March 3, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, September 28, 2021REGISTERED-PRINCIPAL REGISTER
Tuesday, July 13, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 13, 2021PUBLISHED FOR OPPOSITION
Wednesday, June 23, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, June 9, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 9, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, June 9, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, June 7, 2021ASSIGNED TO LIE
Thursday, March 11, 2021TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Monday, March 8, 2021NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Monday, March 8, 2021INQUIRY TO SUSPENSION E-MAILED
Monday, March 8, 2021SUSPENSION INQUIRY WRITTEN
Friday, August 28, 2020NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, August 28, 2020LETTER OF SUSPENSION E-MAILED
Friday, August 28, 2020SUSPENSION LETTER WRITTEN
Thursday, August 27, 2020ASSIGNED TO EXAMINER
Monday, June 15, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, May 30, 2020NEW APPLICATION ENTERED

Related Keywords

ameera field oncology others trials clinical conducting